BIODESIX INC (BDSXXXXX)
Institutional ownership reported to the SEC as of Q2 2026, across 23 quarters.
1
Reporting holders
$6.5M
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Birchview Capital, LP | $6.5M | 286,804 | 3.02% | 23q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $6.5M | 286,804 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $4.2M | 286,804 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $2.0M | 286,804 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $2.2M | 286,804 | 0 | 0 | 1 | 0.0% |
| Q2 2025 | 40 | $9.8M | 34,681,335 | 6 | 7 | 12 | 0.0% |
| Q1 2025 | 58 | $33.4M | 53,314,769 | 9 | 13 | 18 | 0.1% |
| Q4 2024 | 58 | $99.0M | 64,401,902 | 17 | 20 | 7 | 0.5% |
| Q3 2024 | 52 | $121.1M | 67,915,043 | 11 | 12 | 5 | 0.0% |
| Q2 2024 | 42 | $89.8M | 58,675,875 | 15 | 14 | 7 | 0.0% |
| Q1 2024 | 38 | $30.5M | 21,343,768 | 8 | 13 | 5 | 0.0% |
| Q4 2023 | 34 | $43.4M | 22,160,873 | 4 | 13 | 8 | 0.0% |
| Q3 2023 | 33 | $39.1M | 22,360,408 | 10 | 5 | 11 | 0.0% |
| Q2 2023 | 26 | $20.7M | 16,795,300 | 3 | 9 | 4 | 0.0% |
| Q1 2023 | 25 | $21.5M | 11,546,527 | 2 | 12 | 5 | 0.0% |
| Q4 2022 | 24 | $23.7M | 10,310,787 | 10 | 4 | 4 | 0.0% |
| Q3 2022 | 23 | $6.2M | 4,764,024 | 2 | 10 | 5 | 2.1% |
| Q2 2022 | 33 | $6.3M | 3,721,910 | 11 | 6 | 11 | 4.8% |
| Q1 2022 | 42 | $7.1M | 4,176,923 | 6 | 13 | 15 | 0.0% |
| Q4 2021 | 40 | $21.5M | 4,046,840 | 6 | 19 | 8 | 0.6% |
| Q3 2021 | 41 | $34.9M | 4,243,618 | 5 | 17 | 12 | 0.0% |
| Q2 2021 | 47 | $67.6M | 5,120,583 | 7 | 28 | 8 | 0.0% |
| Q1 2021 | 45 | $85.6M | 4,216,600 | 8 | 14 | 15 | 0.0% |
| Q4 2020 | 47 | $75.4M | 3,764,990 | 47 | 0 | 0 | 0.0% |